Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Dyne Therapeutics, Inc. (DYN) had Free Cash Flow of $-106.87M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-115.36M |
|
-- |
|
-- |
|
$122.37M |
|
$-122.37M |
|
$7.01M |
|
$-115.36M |
|
$-115.36M |
|
$-115.36M |
|
$-115.36M |
|
$-115.36M |
|
$-115.36M |
|
$-122.37M |
|
$-122.49M |
|
109.91M |
|
109.91M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$689.50M |
|
$5.75M |
|
$31.57M |
|
$721.07M |
|
$33.88M |
|
-- |
|
$18.22M |
|
$52.10M |
|
$668.97M |
|
$668.97M |
|
$668.97M |
|
113.63M |
|
| Cash Flow Statement Financials | |
$-105.89M |
|
$1.46M |
|
$141.24M |
|
$437.39M |
|
$474.20M |
|
$36.81M |
|
$13.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-106.87M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.24% |
|
-17.24% |
|
-16.00% |
|
-17.24% |
|
$5.89 |
|
$-0.97 |
|
$-0.96 |
|